]>Serum Insulin-Like Growth Factor-1 and Nitric Oxide Levels in Parkinson's Disease : Table 2
Table 2: Nitric oxide, growth hormone, insulin-like growth factor-1, and insulin-like growth factor BP-3 levels of the patients with PD and healthy controls.
PatientsControls
Nitric oxide ( 𝜇 m ol/L)
mea n ± S D 2 . 3 ± 0 , 4 2 . 8 ± 0 . 6 ∗
Growth hormone (ng/mL)
mea n ± S D 0 . 9 ± 0 . 9 0 . 7 ± 1 . 2
Insulin-like growth factor-1 (ng/mL)
(mea n ± S D) 1 3 2 ± 4 2 1 1 3 ± 5 1
Insulin-like growth factor BP-3 ( 𝜇 g /mL)
(mea n ± S D) 3 . 4 ± 0 . 8 3 . 7 ± 1
∗ 𝑃 :.011, P:.52, P:.087, P:.19, respectively.